Literature DB >> 30354343

A-Band Titin Truncation in Zebrafish Causes Dilated Cardiomyopathy and Hemodynamic Stress Intolerance.

Inken G Huttner1,2, Louis W Wang1,2,3, Celine F Santiago1,2, Claire Horvat1, Renee Johnson1, Delfine Cheng4, Marion von Frieling-Salewsky5, Karen Hillcoat6, Timothy J Bemand1, Gunjan Trivedi1, Filip Braet4,7,8, Dan Hesselson2,9, Kevin Alford6, Christopher S Hayward10,2,3, J G Seidman11,12, Christine E Seidman12,13, Michael P Feneley10,2,3, Wolfgang A Linke5, Diane Fatkin1,2,3.   

Abstract

Background Truncating variants in the TTN gene ( TTNtv) are common in patients with dilated cardiomyopathy (DCM) but also occur in the general population. Whether TTNtv are sufficient to cause DCM or require a second hit for DCM manifestation is an important clinical issue. Methods We generated a zebrafish model of an A-band TTNtv identified in 2 human DCM families in which early-onset disease appeared to be precipitated by ventricular volume overload. Cardiac phenotypes were serially assessed from 0 to 12 months using video microscopy, high-frequency echocardiography, and histopathologic analysis. The effects of sustained hemodynamic stress resulting from an anemia-induced hyperdynamic state were also evaluated. Results Homozygous ttna mutants had severe cardiac dysmorphogenesis and premature death, whereas heterozygous mutants ( ttnatv/+) survived into adulthood and spontaneously developed DCM. Six-month-old ttnatv/+ fish had reduced baseline ventricular systolic function and failed to mount a hypercontractile response when challenged by hemodynamic stress. Pulsed wave and tissue Doppler analysis also revealed unsuspected ventricular diastolic dysfunction in ttnatv/+ fish with prolonged isovolumic relaxation and increased diastolic passive stiffness in the absence of myocardial fibrosis. These defects reduced diastolic reserve under stress conditions and resulted in disproportionately greater atrial dilation than observed in wild-type fish. Conclusions Heterozygosity for A-band titin truncation is sufficient to cause DCM in adult zebrafish. Abnormalities of systolic and diastolic reserve in titin-truncated fish reduce stress tolerance and may contribute to a substrate for atrial arrhythmogenesis. These data suggest that hemodynamic stress may be an important modifiable risk factor in human TTNtv-related DCM.

Entities:  

Keywords:  cardiomyopathies; echocardiography; genetics; hemodynamic; titin; zebrafish

Mesh:

Substances:

Year:  2018        PMID: 30354343     DOI: 10.1161/CIRCGEN.118.002135

Source DB:  PubMed          Journal:  Circ Genom Precis Med        ISSN: 2574-8300


  13 in total

1.  Variant Interpretation for Dilated Cardiomyopathy: Refinement of the American College of Medical Genetics and Genomics/ClinGen Guidelines for the DCM Precision Medicine Study.

Authors:  Ana Morales; Daniel D Kinnamon; Elizabeth Jordan; Julia Platt; Matteo Vatta; Michael O Dorschner; Carl A Starkey; Jonathan O Mead; Tomohiko Ai; Wylie Burke; Julie Gastier-Foster; Gail P Jarvik; Heidi L Rehm; Deborah A Nickerson; Ray E Hershberger
Journal:  Circ Genom Precis Med       Date:  2020-03-11

Review 2.  Titin-related Cardiomyopathy: Is it a Distinct Disease?

Authors:  Celine F Santiago; Inken G Huttner; Diane Fatkin
Journal:  Curr Cardiol Rep       Date:  2022-06-27       Impact factor: 3.955

Review 3.  Mechanisms of TTNtv-Related Dilated Cardiomyopathy: Insights from Zebrafish Models.

Authors:  Celine F Santiago; Inken G Huttner; Diane Fatkin
Journal:  J Cardiovasc Dev Dis       Date:  2021-01-25

Review 4.  Modeling Inherited Cardiomyopathies in Adult Zebrafish for Precision Medicine.

Authors:  Yonghe Ding; Haisong Bu; Xiaolei Xu
Journal:  Front Physiol       Date:  2020-11-19       Impact factor: 4.566

5.  Protein tyrosine phosphatase receptor-ζ1 deletion triggers defective heart morphogenesis in mice and zebrafish.

Authors:  Stamatiki Katraki-Pavlou; Pinelopi Kastana; Dimitris Bousis; Despoina Ntenekou; Aimilia Varela; Constantinos H Davos; Sophia Nikou; Eleni Papadaki; Grigorios Tsigkas; Emmanouil Athanasiadis; Gonzalo Herradon; Constantinos M Mikelis; Dimitris Beis; Evangelia Papadimitriou
Journal:  Am J Physiol Heart Circ Physiol       Date:  2021-11-12       Impact factor: 5.125

6.  Inhibition of mTOR or MAPK ameliorates vmhcl/myh7 cardiomyopathy in zebrafish.

Authors:  Haisong Bu; Yonghe Ding; Jiarong Li; Ping Zhu; Yu-Huan Shih; Mingmin Wang; Yuji Zhang; Xueying Lin; Xiaolei Xu
Journal:  JCI Insight       Date:  2021-12-22

7.  Rationale and design of the PROspective ATHletic Heart (Pro@Heart) study: long-term assessment of the determinants of cardiac remodelling and its clinical consequences in endurance athletes.

Authors:  Ruben De Bosscher; Christophe Dausin; Kristel Janssens; Jan Bogaert; Adrian Elliott; Olivier Ghekiere; Caroline M Van De Heyning; Prashanthan Sanders; Jonathan Kalman; Diane Fatkin; Lieven Herbots; Rik Willems; Hein Heidbuchel; André La Gerche; Guido Claessen
Journal:  BMJ Open Sport Exerc Med       Date:  2022-03-18

8.  Haploinsufficiency of mechanistic target of rapamycin ameliorates bag3 cardiomyopathy in adult zebrafish.

Authors:  Yonghe Ding; Alexey V Dvornikov; Xiao Ma; Hong Zhang; Yong Wang; Matthew Lowerison; Rene R Packard; Lei Wang; Jun Chen; Yuji Zhang; Tzung Hsiai; Xueying Lin; Xiaolei Xu
Journal:  Dis Model Mech       Date:  2019-10-01       Impact factor: 5.758

Review 9.  Modifications of Titin Contribute to the Progression of Cardiomyopathy and Represent a Therapeutic Target for Treatment of Heart Failure.

Authors:  Charles Tharp; Luisa Mestroni; Matthew Taylor
Journal:  J Clin Med       Date:  2020-08-26       Impact factor: 4.241

10.  Titin-Related Dilated Cardiomyopathy: The Clinical Trajectory and the Role of Circulating Biomarkers in the Clinical Assessment.

Authors:  Przemysław Chmielewski; Grażyna Truszkowska; Ilona Kowalik; Małgorzata Rydzanicz; Ewa Michalak; Małgorzata Sobieszczańska-Małek; Maria Franaszczyk; Piotr Stawiński; Małgorzata Stępień-Wojno; Artur Oręziak; Michał Lewandowski; Przemysław Leszek; Maria Bilińska; Tomasz Zieliński; Rafał Płoski; Zofia T Bilińska
Journal:  Diagnostics (Basel)       Date:  2021-12-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.